Fragoso DJ, Mainero RF

Language: Spanish
References: 11
Page: 439-447
PDF size: 171.74 Kb.

ABSTRACT

Background: Breast cancer incidence associated with hormonal replacement therapy have been evaluated in many studies, which have found a hard to proof increment due to several particular patient factors.
Aims: Many studies have been assessed the incidence of breast cancer in relation to the use of replacement therapy, however it is difficult to prove absolutely, every women has a different risk, influenced by genetic factors, nuliparity, late parity, menarche, menopause, use of estrogens, mastographic density and previous mammary disease.
Objective: To identify if there is an increase in the number of cases of breast cancer in postmenopausal women with replacement therapy, with low and medium level in Mainero’s classification.
Material and methods: Cohort study prospective, and closed in 316 women with a 0, 1 or 2 result according to the Mainero’s classification. 25 were excluded, 74 with a score of 0, 193 score of 1 and 24 score of 2, we followed all the women for 60 to 90 months with replacement therapy.
Results: We did not find patients with breast cancer and replacement therapy.
Conclusion: Mainero's classification is an easy option to evaluate and decide replacement therapy taking the oncology risk.

REFERENCES

1. Lineamiento técnico médico para la atención del climaterio y la menopausia. 2730-014-003.

2. Primer Consenso Nacional Multidisciplinario sobre terapia de remplazo hormonal. Revista del climaterio 2004;7:156-79.

3. Copeland M. Bland K. Manejo multidisciplinario de las enfermedades benignas y malignas de la mama. Cancer 2000;2:1495-508.

4. Harris J, Lippman M, et al. Diseases of the Breast. Cancer 2004;2:15-24.

5. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997;350:1047-59.

6. WHI. JAMA 2002;288:321-33.

7. Chlebowski RT, Hendrix SL, Langer RD, et al. WHI Investigators, influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the women’s health initiative randomized trial. JAMA 2003; 289:3243-53.

8. M anual de Normas y Procedimientos en Ginecología del Hospital Luis Castelazo Ayala, 2005. Enfermedades de la glándula mamaria.

9. Gram IB. Percentage density, Wolfe’s and Tabar’s mammographic patterns: agreement and association with risk factors for breast cancer. Breast Cancer Research 2005;7:854-61.

10. Domchek S, Eisen A, et al. Application of Breast Cancer Risk Prediction Models in Clinical Practice. J Clin Oncol 2003;21:593-601.

11. Carranza LS. Atención integral del climaterio. 2ª ed. México: Masson Doyma, 2002;pp:311-23.